Carbylan Therapeutics CEO T Crockett's 2020 pay falls 47% to $1.7M
Carbylan Therapeutics reports 2020 executive compensation
By ExecPay News
Published: August 25, 2020
Carbylan Therapeutics reported fiscal year 2020 executive compensation information on August 25, 2020.
In 2020, three executives at Carbylan Therapeutics received on average a compensation package of $1.2M, a 41% decrease compared to previous year.
Average pay of disclosed executives at Carbylan Therapeutics
T. Andrew Crockett, Chief Executive Officer, received $1.7M in total, which decreased by 47% compared to 2019. 67% of Crockett's compensation, or $1.2M, was in option awards. Crockett also received $556K in salary and $12K in other compensation.
Benjamin L. Palleiko, Chief Financial Officer, received a compensation package of $1M, which decreased by 51% compared to previous year. 57% of the compensation package, or $582K, was in option awards.
Christopher M. Yea, Chief Development Officer, earned $926K in 2020, a 35% decrease compared to previous year.
Carbylan Therapeutics' fiscal year ends on April 30.
Related executives
You may also like
Source: SEC filing on August 25, 2020.